• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定肝细胞癌经动脉化疗栓塞术(TACE)治疗疗效的血清生物标志物。

Identifying serum biomarkers for TACE therapy efficiency of hepatocellular carcinoma.

作者信息

Li Chang-yu, Wang Xiao-lin, Wang Jian-hua, Yan Zhi-ping, Gong Gao-quan, Cheng Jie-min, Chen Yi, Liu Ling-xiao, Li Guo-ping, Wang Cheng-gang, Shi Dong-hua

机构信息

Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Front Biosci (Elite Ed). 2011 Jan 1;3(1):212-20. doi: 10.2741/e235.

DOI:10.2741/e235
PMID:21196300
Abstract

Transcatheter Arterial Chemoembolization (TACE) is the first line of treatment in inoperable hepatocellular carcinoma. Magnetic affinity beads can be used to extract peptides from un-fractionated serum samples. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) can detect the presence and the molecular mass of peptides. In this study, we used a highly optimized ClinProt-matrix-assisted laser desorption/ionization time-of flight mass spectrometer (MALDI-TOF-MS) to screen hepatocellular carcinoma markers for TACE. 40 sera from 20 patients, including before and after TACE to explore those biomarkers, might be related with therapy efficiency, and some of the patients who received another therapy were analyzed as well. The spectra were analyzed statistically using FlexAnalysis™ and Clin-Prot™ bioinformatic software. The seven most significant differential peaks (p < 0.0.5) were selected out by ClinProTool software to identify hepatocellular carcinoma markers for TACE therapy. Furthermore, the differential peptide of 3883Da was identified as plasma serine protease inhibitor precursor (Protein C inhibitor). This study provides a direct link between peptide marker profiles and TACE therapy, and the markers may have clinical utility for monitoring efficiency of therapy.

摘要

经导管动脉化疗栓塞术(TACE)是不可切除肝细胞癌的一线治疗方法。磁性亲和珠可用于从未经分离的血清样本中提取肽段。基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)可检测肽段的存在及其分子量。在本研究中,我们使用高度优化的ClinProt-基质辅助激光解吸/电离飞行时间质谱仪(MALDI-TOF-MS)筛选用于TACE的肝细胞癌标志物。收集了20例患者的40份血清样本,包括TACE治疗前后的样本,以探索可能与治疗效果相关的生物标志物,同时也对部分接受其他治疗的患者进行了分析。使用FlexAnalysis™和Clin-Prot™生物信息软件对光谱进行统计学分析。通过ClinProTool软件选出七个最显著的差异峰(p<0.05),以鉴定用于TACE治疗的肝细胞癌标志物。此外,鉴定出分子量为3883Da的差异肽为血浆丝氨酸蛋白酶抑制剂前体(蛋白C抑制剂)。本研究建立了肽标志物谱与TACE治疗之间的直接联系,这些标志物可能在监测治疗效果方面具有临床应用价值。

相似文献

1
Identifying serum biomarkers for TACE therapy efficiency of hepatocellular carcinoma.鉴定肝细胞癌经动脉化疗栓塞术(TACE)治疗疗效的血清生物标志物。
Front Biosci (Elite Ed). 2011 Jan 1;3(1):212-20. doi: 10.2741/e235.
2
Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.经肝动脉化疗栓塞术治疗后,介入治疗后白细胞介素 6(IL-6)水平而非治疗前或 IL-6 的动态变化,可作为肝细胞癌早期肿瘤反应的实用标志物。
Oncologist. 2019 Dec;24(12):e1489-e1495. doi: 10.1634/theoncologist.2018-0669. Epub 2019 Jun 27.
3
Identification of novel serum biomarkers for gastric cancer by magnetic bead.利用磁珠鉴定胃癌的新型血清生物标志物
Front Biosci (Elite Ed). 2010 Jun 1;2(3):961-71. doi: 10.2741/e155.
4
Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization.循环中的miR-26a、miR-106b、miR-107和miR-133b可根据肝细胞癌患者对经动脉化疗栓塞术的反应对其进行分层。
Clin Biochem. 2019 Mar;65:45-52. doi: 10.1016/j.clinbiochem.2019.01.002. Epub 2019 Jan 15.
5
Transcatheter Arterial Chemoembolisation Combined with Radiofrequency Ablation on Hepatocellular Carcinoma and Levels of Relevant Markers.经导管动脉化疗栓塞联合射频消融治疗肝细胞癌及相关标志物水平。
J Coll Physicians Surg Pak. 2020 Mar;30(3):259-262. doi: 10.29271/jcpsp.2020.03.259.
6
Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.基于质谱分析的肝细胞癌骨转移血清肽谱分析
World J Gastroenterol. 2014 Mar 21;20(11):3025-32. doi: 10.3748/wjg.v20.i11.3025.
7
Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.用于发现肝细胞癌肽和聚糖生物标志物的基质辅助激光解吸电离飞行时间质谱数据分析。
J Proteome Res. 2008 Feb;7(2):603-10. doi: 10.1021/pr0705237. Epub 2008 Jan 12.
8
Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.用于头颈部癌治疗前后样本中表达谱分析和生物标志物发现的血清蛋白差异捕获
Laryngoscope. 2008 Jan;118(1):61-8. doi: 10.1097/MLG.0b013e31814cf389.
9
Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.肝细胞癌经动脉化疗栓塞术后血清缺氧诱导因子-1α变化的预后价值
Clin Exp Med. 2021 Feb;21(1):109-120. doi: 10.1007/s10238-020-00667-8. Epub 2020 Oct 9.
10
Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.使用甲胎蛋白和异常凝血酶原评估接受经动脉化疗栓塞术的肝细胞癌患者的肿瘤反应
Chirurgia (Bucur). 2018 Jul-Aug;113(4):524-533. doi: 10.21614/chirurgia.113.4.524.

引用本文的文献

1
Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma.经动脉化疗栓塞术联合瘤内注射顺铂治疗肝细胞癌的可行性评估
Open Med (Wars). 2015 Dec 17;10(1):434-439. doi: 10.1515/med-2015-0075. eCollection 2015.
2
Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations.采用无标记定量蛋白质组学技术对两个西非人群的肝细胞癌进行蛋白质谱分析。
PLoS One. 2013 Jul 30;8(7):e68381. doi: 10.1371/journal.pone.0068381. Print 2013.